Mirae Asset Global Etfs Holdings Ltd. Kymera Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 24,570 shares of KYMR stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,570Holding current value
$1.27 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
168Shares Held
63.6MCall Options Held
22.6KPut Options Held
14.4K-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$331 Million0.02% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$311 Million2.38% of portfolio
-
Atlas Venture Life Science Advisors, LLC5.35MShares$277 Million21.28% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$268 Million4.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$250 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.84B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...